Harish Manwani - May 3, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by Power of Attorney for Harish Manwani
Stock symbol
GILD
Transactions as of
May 3, 2023
Transactions value $
$779,007
Form type
4
Date filed
5/4/2023, 05:51 PM
Previous filing
Apr 20, 2023
Next filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock +Grant/Award $0 +1,887 +19.87% $0.00 11,382 May 3, 2023 Direct F1
transaction GILD Common Stock -Tax liability -$29,238 -368 -3.23% $79.45 11,014 May 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) +Grant/Award $808,245 +10,173 $79.45 10,173 May 3, 2023 Common Stock 10,173 $79.45 Direct F2

Explanation of Responses:

Id Content
F1 Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023.
F2 100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023.